Dafazin-5

Composition: Dapagliflozin 5 mg

Dafazin-5 is an SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor used for the management of Type 2 Diabetes Mellitus. It reduces blood sugar levels by preventing the kidneys from reabsorbing glucose and instead promotes its excretion through urine. This mechanism helps lower fasting as well as post-meal blood glucose levels. Dapagliflozin 5 mg is often prescribed when lifestyle changes and first-line medications like metformin are not sufficient. It also offers added clinical advantages, including weight reduction, mild blood pressure control, and cardiovascular and kidney protective benefits. The medication is taken once daily, with or without food, and works best when combined with dietary modifications, exercise, and regular monitoring.

Uses:

• Treatment of Type 2 Diabetes Mellitus
• 
  
• Reduction of HbA1c levels
• 
  
• Assists in weight management
• 
  
• Lowers risk of heart failure-related hospitalization
• 
  
• Offers renal protection in suitable patients

Side Effects:

• Frequent urination
• 
  
• Urinary tract infections (UTIs)
• 
  
• Genital fungal infections
• 
  
• Dehydration, dizziness
• 
  
• Low blood pressure
• 
  
• Rare risk of ketoacidosis

Other Details:

• Not suitable for Type 1 diabetes or patients with severe renal impairment
• 
  
• Hydration should be maintained to avoid dehydration
• 
  
• Kidney function assessments are recommended
• 
  
• Dose adjustments may be needed with insulin or other anti-diabetic drugs